Feasibility of Axillary Reverse Mapping and Clinicopathological Features Predicting ARM Node Metastasis in Breast Cancer—a Pilot Study

被引:11
|
作者
Kumar K.S. [1 ]
Hemanth G.N. [1 ]
Panjwani P.K. [2 ]
Manjunath S. [1 ]
Ramesh R.S. [1 ]
Burrah R. [1 ]
Rout P. [2 ]
Ramu D. [1 ]
Joseph E.P. [1 ]
Chandran R. [1 ]
Prasad C. [1 ]
Goel V. [1 ]
Divya S. [2 ]
机构
[1] Department of Surgical Oncology, St. John’s Medical College Hospital, Sarjapura Road, Bangalore
[2] Department of Pathology, St. John’s Medical College Hospital, Sarjapura Road, Bangalore
关键词
Axillary reverse mapping; Sentinel node;
D O I
10.1007/s13193-016-0578-1
中图分类号
学科分类号
摘要
The axillary reverse mapping (ARM) technique has been described as an attempt to map and preserve the upper extremity lymphatic drainage during axillary lymph node dissection (ALND) and/or SLNB. This technique is based on the hypothesis that the lymphatic pathway from the upper extremity is not involved by metastasis from primary breast cancer. The ARM node/s however, has been found, in various studies, to be involved with metastatic foci in patients with extensive axillary lymph node metastases. Therefore, the oncological safety of this procedure has not yet been determined. In this pilot study, we assessed the ARM node intraoperatively for various parameters and compared it to final HPR, to try and determine the oncologic safety of preserving the ARM node. Seventy-two breast cancer patients were screened for this prospective pilot study which was planned to recruit 20 patients. The study was initiated on May 2014, 20 patients were recruited till July 2015. Eligibility criterion was as follows: patients requiring primary axillary lymph node dissection based on a clinically positive axilla. Forty-five patients were ineligible because they had either received neoadjuvant chemotherapy or underwent previous axillary surgery or axillary radiation (exclusion criteria). Seven patients refused to give consent. ARM node identification rate was 75%. The most common location of the ARM node was lateral to the latissimus dorsi pedicle (42.10%), none of them being malignant. None of the oval or firm nodes were malignant. Tumor deposits were identified in 13%. Fine-needle aspiration cytology (FNAC) had 100% specificity, 94.4% negative predictive value, 100% positive predictive value, and 50% sensitivity. ARM is feasible using blue dye alone, with an acceptable identification rate. Location, consistency, and intraoperative FNAC of the ARM node, put together, may be reliable parameters to predict involvement of the ARM node with metastasis. © 2016, Indian Association of Surgical Oncology.
引用
收藏
页码:119 / 122
页数:3
相关论文
共 50 条
  • [41] A multivariable model of ultrasound and clinicopathological features for predicting axillary nodal burden of breast cancer: potential to prevent unnecessary axillary lymph node dissection
    Lei Yang
    Yifan Gu
    Bing Wang
    Ming Sun
    Lei Zhang
    Lei Shi
    Yanfei Wang
    Zheng Zhang
    Yifei Yin
    BMC Cancer, 23
  • [42] A multivariable model of ultrasound and clinicopathological features for predicting axillary nodal burden of breast cancer: potential to prevent unnecessary axillary lymph node dissection
    Yang, Lei
    Gu, Yifan
    Wang, Bing
    Sun, Ming
    Zhang, Lei
    Shi, Lei
    Wang, Yanfei
    Zhang, Zheng
    Yin, Yifei
    BMC CANCER, 2023, 23 (01)
  • [43] Axillary reverse mapping in breast cancer surgery - functional study
    Pavlista, David
    Dostalek, Lukas
    Velenska, Zuzana
    NEOPLASMA, 2022, 69 (02) : 425 - 429
  • [44] The value of ultrasonic parameters combined with clinicopathological parameters in predicting axillary lymph node metastasis in triple-negative breast cancer
    Zhao, Juan
    Pan, Haiyang
    Zhang, Shikun
    Zhang, Qing
    Zhang, Ting
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2023, 44 (05) : 104 - 109
  • [45] Clinicopathological Characteristics of Axillary Lymph Node Metastasis in Lung Cancer
    Kong, Yue
    Chen, Ming
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S679 - S680
  • [46] Breast cancer and Axillary Reverse Mapping Decorative tattoo pigment in an axillary non sentinel lymph node
    Baron, M.
    Forestier-Lebreton, F.
    Muller, M.
    Teig, B.
    Laberge-Le Couteulx, S.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2008, 36 (7-8): : 779 - 781
  • [47] A Phase I Study to Assess the Feasibility and Oncologic Safety of Axillary Reverse Mapping in Breast Cancer Patients
    Bedrosian, Isabelle
    Babiera, Gildy V.
    Mittendorf, Elizabeth A.
    Kuerer, Henry M.
    Pantoja, Laura
    Hunt, Kelly K.
    Krishnamurthy, Savitri
    Meric-Bernstam, Funda
    CANCER, 2010, 116 (11) : 2543 - 2548
  • [48] The involvement of axillary reverse mapping nodes in patients with node-positive breast cancer
    Noguchi, Masakuni
    Inokuchi, Masafumi
    Yokoi-Noguchi, Miki
    Morioka, Emi
    Haba, Yusuke
    EJSO, 2023, 49 (10):
  • [49] Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?
    Tausch, C.
    Baege, A.
    Dietrich, D.
    Vergin, I.
    Heuer, H.
    Heusler, R. Haldemann
    Rageth, C.
    EJSO, 2013, 39 (08): : 880 - 886
  • [50] A Nomogram for Predicting the Pathological Response of Axillary Lymph Node Metastasis in Breast Cancer Patients
    Jin, Xi
    Jiang, Yi-Zhou
    Chen, Sheng
    Shao, Zhi-Ming
    Di, Gen-Hong
    SCIENTIFIC REPORTS, 2016, 6